Cabozantinib 40 mg Tablets

Get a Price/Quote

MOQ : 100 Packs

Cabozantinib 40 mg Tablets Specification

Indication
Used for the treatment of advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer

Dosage Form
Tablet

Salt Composition
Cabozantinib (as S-malate) 40 mg

Feature
Oral targeted therapy, high efficacy, convenient dosing

Ingredients

Application
Oncology / Cancer treatment

Physical Color/Texture
Yellow film-coated, capsule-shaped tablet

Storage Instructions
Store below 30C (86F), protect from moisture and light

Shelf Life
24 to 36 months (as per packaging)

Packaging Type
Blister pack or bottle

Caution
Use with caution in hepatic or renal impairment, pregnant or breastfeeding women

Contraindications
Hypersensitivity to Cabozantinib or any component of the tablet

Packaging Size
30 tablets or as per requirement

Patient Population
Adult

Marking
Engraved for identification as per manufacturer's specification

ATC Code
L01XE26

Regulatory Approvals
US FDA/EU approvals where marketed

Strength
40 mg

Prescription Status
Prescription only (Rx) medicine

Shape
Capsule-shaped

Administration Route
Oral

Cabozantinib 40 mg Tablets Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Cabozantinib 40 mg Tablets

Cabozantinib 40 mg Tablets are a renowned and cost-effective oral targeted therapy for adults diagnosed with advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. Manufactured to optimum standards with US FDA and EU regulatory approvals, it is available in capsule-shaped, yellow, film-coated tablets, each containing 40 mg Cabozantinib (as S-malate). Find flexibility in packaging-either blister pack or bottle-to match your requirements, and benefit from convenient dosing. Try now to experience terrific efficacy and quality, distributed by trusted suppliers and traders across India. Prescription required.

Cabozantinib Tablets: Optimum Efficacy for Oncology Applications

The primary area of application for Cabozantinib 40 mg Tablets is oncology, focusing on the treatment of advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. With usage type defined as prescription only, these tablets are intended for adult patients requiring effective cancer therapy. Use type is oral administration, allowing for convenient dosing at home or in clinical settings. This medicine exemplifies a targeted approach in cancer care, supporting improved patient outcomes.

Certifications, Samples, and Market Availability of Cabozantinib Tablets

Cabozantinib 40 mg Tablets are manufactured with strict adherence to renowned international certifications, including US FDA and relevant EU approvals. Samples may be available upon request to help healthcare providers evaluate product specifications before outlay. Orders are efficiently dispatched and prepared for drop-off across the main domestic market in India, ensuring reliable and timely supply for pharmacies, hospitals, and authorized distributors. Trust in a seamless process for all your oncological supply requirements.

FAQ's of Cabozantinib 40 mg Tablets:

Q: How should Cabozantinib 40 mg Tablets be taken?

A: Cabozantinib 40 mg Tablets are administered orally, as directed by your healthcare provider. It is important to follow the prescribed dosage and not to crush or chew the tablet. Consume with or without food, based on your physician's advice.

Q: What are the benefits of choosing Cabozantinib for cancer treatment?

A: Cabozantinib offers a targeted oral therapy option with high efficacy for treating advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. It is recognized for its convenient dosing and strong regulatory approvals.

Q: When should I avoid using Cabozantinib 40 mg Tablets?

A: You should avoid using this medication if you have a known hypersensitivity to Cabozantinib or any component of the tablet. It should also be used with caution in patients with hepatic or renal impairment and in pregnant or breastfeeding women.

Q: Where are Cabozantinib Tablets typically available?

A: These tablets are available through licensed pharmacies, hospitals, and authorized distributors, especially in markets where US FDA/EU approvals are recognized, including India.

Q: What is the process for obtaining a sample of Cabozantinib 40 mg Tablets?

A: Healthcare institutions or professionals can request a sample from authorized suppliers or traders. This allows for evaluation before committing to a larger outlay. Delivery is arranged and dispatched as per local regulations.